Save
Email
Print
Share
RSSStay up to date!
Get all of ScienceDaily's Ovarian Cancer headlines automatically delivered to you every day by subscribing for free via:
Browse News Stories
25 to 36 of 330 stories (45 over past year)
view headlines only
-
Engineered Human T Cells Can Eradicate Deadly Human Ovarian Cancer in Immune-Deficient Mice
August 8, 2011 — Medical researchers have shown for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient ... > full story -
New Peptides to Fight Ovarian Cancer Drug Resistance
August 1, 2011 — Italian and German scientists have designed peptides to target the protein-protein interface of a key enzyme in DNA synthesis crucial for cancer growth. The peptides act by a novel inhibitory ... > full story -
Mismatch Between Cancer Genetics Counseling and Testing Guidelines and Physician Practices
July 25, 2011 — A new analysis has found that many doctors report that they do not appropriately offer breast and ovarian cancer counseling and testing services to their female patients. The study indicates that ... > full story -
Therapy Appears to Reduce Rate of Chemotherapy-Induced Early Menopause for Women With Breast Cancer
July 19, 2011 — Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a ... > full story -
New Anti-Cancer Agents Show Promise for Treating Aggressive Breast Cancers
July 18, 2011 — Some of the most aggressive forms of breast cancer are more vulnerable to chemotherapy when it is combined with a new class of anti-cancer agent, researchers have ... > full story -
Cancer Stem Cells Recruit Normal Stem Cells to Fuel Ovarian Cancer
July 18, 2011 — Researchers have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to ... > full story -
Low Dose Naltrexone: Harnessing the Body's Own Chemistry to Treat Human Ovarian Cancer
July 12, 2011 — Researchers have discovered that a low dose of the opioid antagonist naltrexone (LDN) markedly suppresses progression of human ovarian cancer transplanted into mice. LDN's antitumor action was ... > full story -
Researchers Characterize Biomechanics of Ovarian Cells According to Phenotype at Stages of Cancer
July 5, 2011 — Using ovarian surface epithelial cells from mice, researchers have released findings from a study that they believe will help in cancer risk assessment, cancer diagnosis, and treatment ... > full story -
Cancer Genome Atlas Completes Detailed Ovarian Cancer Analysis
June 30, 2011 — As part of the Cancer Genome Atlas project, North Carolina researchers have contributed to the most comprehensive an integrated view of cancer genes for any cancer type produced to ... > full story -
Ovarian Cancer Cells Bully Their Way Through Tissue
June 14, 2011 — Ovarian cancer cells use mechanical force to move through tissue and colonize additional organs. A new study contributes to a body of work that will inform future treatments. Eventually, it might be ... > full story -
Scientists Image Beginning Stages of Ovarian Cancer Growth With Time-Lapse Technique
June 14, 2011 — Scientists have created a laboratory model using time-lapse video microscopic technology that allows observation of early stages of ovarian cancer ... > full story -
PET Imaging Determines Malignancy in Potential Ovarian Cancer Cases
June 6, 2011 — A new study may provide a novel tool for detection of malignant-stage ovarian cancer. Researchers found that positron emission tomography and computed tomography (PET/CT), which images both ... > full story
Recommend this page on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools:
Search ScienceDaily
Number of stories in archives: 118,862
more 
